Scarica l'app Stockscreener
9.27
3.24%
-0.31
Precedente Chiudi:
$9.58
Aprire:
$9.54
Volume 24 ore:
6,066
Relative Volume:
0.09
Capitalizzazione di mercato:
$46.51M
Reddito:
$34.77M
Utile/perdita netta:
$-74.04M
Rapporto P/E:
-1.1565
EPS:
-8.0157
Flusso di cassa netto:
$-79.76M
1 W Prestazione:
-12.46%
1M Prestazione:
+11.96%
6M Prestazione:
-6.76%
1 anno Prestazione:
-79.63%
Intervallo 1D:
$9.20
$9.59
Intervallo di 1 settimana:
$9.20
$10.60
Portata 52W:
$5.21
$70.75
Mersana Therapeutics Inc Stock (MRSN) Company Profile
Nome
Mersana Therapeutics Inc
Settore
Industria
Telefono
617-498-0020
Indirizzo
840 MEMORIAL DRIVE, CAMBRIDGE
Confronta MRSN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRSN
Mersana Therapeutics Inc
|
9.32 | 47.81M | 34.77M | -74.04M | -79.76M | -8.0157 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.88 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.71 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.01 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mersana Therapeutics Inc Stock (MRSN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-06 | Iniziato | William Blair | Outperform |
| 2024-11-15 | Ripresa | Citigroup | Buy |
| 2024-03-19 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-29 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-02-29 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2024-02-29 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-12-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-28 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-07-27 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-07-27 | Downgrade | Citigroup | Buy → Neutral |
| 2023-07-27 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-07-27 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-07-27 | Downgrade | Truist | Buy → Hold |
| 2023-07-27 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-06-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-06-15 | Iniziato | Guggenheim | Buy |
| 2023-03-16 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-01-20 | Iniziato | Citigroup | Buy |
| 2022-11-21 | Iniziato | Truist | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-08-30 | Iniziato | H.C. Wainwright | Buy |
| 2021-03-31 | Iniziato | Credit Suisse | Neutral |
| 2020-12-03 | Iniziato | Stifel | Buy |
| 2020-09-29 | Ripresa | JP Morgan | Neutral |
| 2020-04-29 | Iniziato | BTIG Research | Buy |
| 2020-01-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-03-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-11-14 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-05-08 | Iniziato | Robert W. Baird | Outperform |
| 2018-03-19 | Downgrade | JP Morgan | Overweight → Neutral |
Mostra tutto
Mersana Therapeutics Inc Borsa (MRSN) Ultime notizie
Can you recover from losses in Mersana Therapeutics Inc.Weekly Stock Recap & Long-Term Growth Plans - newser.com
How Mersana Therapeutics Inc. stock benefits from global expansionFed Meeting & Daily Risk Controlled Trade Plans - newser.com
News impact scoring models applied to Mersana Therapeutics Inc.July 2025 Momentum & Reliable Intraday Trade Alerts - newser.com
Price action breakdown for Mersana Therapeutics Inc.2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Can Mersana Therapeutics Inc. (0M4) stock stage a strong rebound this quarterJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
Why Mersana Therapeutics Inc. stock could rally in 2025Earnings Miss & Community Supported Trade Ideas - newser.com
Can Mersana Therapeutics Inc. (0M4) stock sustain breakout momentumBond Market & Weekly Momentum Stock Picks - newser.com
How cyclical is Mersana Therapeutics Inc. (0M4) stock compared to rivals2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com
Using data filters to optimize entry into Mersana Therapeutics Inc.Weekly Investment Report & Reliable Entry Point Alerts - newser.com
Detecting price anomalies in Mersana Therapeutics Inc. with AIJuly 2025 Market Mood & Precise Buy Zone Tips - newser.com
Earnings visualization tools for Mersana Therapeutics Inc.Market Trend Report & Capital Protection Trade Alerts - newser.com
How Mersana Therapeutics Inc. (0M4) stock responds to job market shiftsJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - newser.com
Heatmap analysis for Mersana Therapeutics Inc. and competitorsJuly 2025 Reactions & Daily Profit Focused Stock Screening - newser.com
What momentum shifts mean for Mersana Therapeutics Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
Why Mersana Therapeutics Inc. stock remains a top recommendationTreasury Yields & Proven Capital Preservation Tips - newser.com
How Mersana Therapeutics Inc. (0M4) stock reacts to weak economyTrade Volume Report & High Conviction Buy Zone Picks - newser.com
Is Mersana Therapeutics Inc. stock ready for a breakoutMarket Performance Recap & Reliable Breakout Forecasts - newser.com
Does Mersana Therapeutics Inc. qualify in momentum factor screeningShare Buyback & Free Reliable Trade Execution Plans - newser.com
Should you hold or exit Mersana Therapeutics Inc. now2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
Published on: 2025-10-30 02:25:49 - newser.com
Mersana Therapeutics Inc Azioni (MRSN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.21%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):